Royal DSM, a global purpose-led, science-based company in Nutrition, Health and Sustainable Living, and Clariant, a focused, sustainable and innovative specialty chemical company, announced an agreement for DSM to take over certain parts of Clariant’s 3D printing business portfolio. The agreement allows DSM to offer customers rapid product development iterations for filaments and pellets based on application needs.
As additive manufacturing technology is increasingly adopted for industrial production, customers are looking for materials to match their existing product portfolio and production processes. The combination of DSM’s filament and pellet capabilities and former Clariant 3D printing activities will be able to better serve those needs, bringing customers quick tweaking of high performance filaments and pellets based on market needs.
The upcoming integration of these assets enables DSM to strengthen its engineering grade filament, pellet and powder portfolio. Customers will also benefit from faster product tweaks based on application needs thanks to the Clariant team’s experience in fast and market-driven product development using a dedicated, highly flexible and high-speed compounding setup. The transaction includes part of Clariant 3D printing team, selection of their portfolio and pipeline of engineering-grade filament and pellet materials and customer relations, expertise in powder development, and a small production line for fast ramp-up of small batches.